Oral BPC-157 for Gastrointestinal Conditions Injectable BPC-157 for Musculoskeletal Conditions Injection Technique and Patient Education All patients receiving injectable BPC-157 are provided with: Detailed written instructions for reconstitution, storage, and administration In-person or video training on proper subcutaneous injection technique Sharps disposal containers and guidance on safe disposal 24-hour clinical contact for questions or concerns Most patients self-administer injections after the first week of supervised dosing
The problems related to Prader-Willi syndrome include: Respiratory problems such as sleep apnea, reduced breathing during sleep, aspiration pneumonia or respiratory failure due to obesity
doi: 10.1172/JCI78490 92 IvanovIHeydeckDHofheinzKRoffeisJO'DonnellVBKuhnHet al
doi:10.1089/cap.2015.0146CrossRefGoogle ScholarPubMed Hardan, AY, Hendren, RL, Aman, MG, et al
Intermediate hyperglycemia in early pregnancy: a South Asian perspective
Some protocols use both